The therapeutic age of the neonatal Fc receptor

M Pyzik, LK Kozicky, AK Gandhi… - Nature Reviews …, 2023 - nature.com
IgGs are essential soluble components of the adaptive immune response that evolved to
protect the body from infection. Compared with other immunoglobulins, the role of IgGs is …

A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology

D Pastori, VM Cormaci, S Marucci, G Franchino… - International Journal of …, 2023 - mdpi.com
Venous thromboembolism (VTE) is the third most common cause of death worldwide. The
incidence of VTE varies according to different countries, ranging from 1–2 per 1000 person …

Systemic diseases and the cornea

R Shah, C Amador, K Tormanen, S Ghiam… - Experimental eye …, 2021 - Elsevier
There is a number of systemic diseases affecting the cornea. These include endocrine
disorders (diabetes, Graves' disease, Addison's disease, hyperparathyroidism), infections …

A practical approach to the management of cerebral amyloid angiopathy

MG Kozberg, V Perosa, ME Gurol… - … Journal of Stroke, 2021 - journals.sagepub.com
Cerebral amyloid angiopathy is a common small vessel disease in the elderly involving
vascular amyloid-β deposition. Cerebral amyloid angiopathy is one of the leading causes of …

The pathophysiology of the antiphospholipid syndrome: a perspective from the blood coagulation system

R Arreola-Diaz, A Majluf-Cruz… - Clinical and Applied …, 2022 - journals.sagepub.com
The antiphospholipid syndrome (APS), a systemic autoimmune disease characterized by a
hypercoagulability associated to vascular thrombosis and/or obstetric morbidity, is caused …

Metabolic syndrome, autoimmunity and rheumatic diseases

G Medina, O Vera-Lastra, AL Peralta-Amaro… - Pharmacological …, 2018 - Elsevier
Metabolic syndrome (MetS) is a cluster of metabolic and cardiovascular (CV) risk factors
including obesity and visceral adiposity, insulin resistance, dyslipidemia and hypertension …

Prevalence of aPhosphatidylserine/prothrombin antibodies and association with antiphospholipid antibody profiles in patients with antiphospholipid syndrome: A …

R Zhu, CY Cheng, Y Yang, G Denas, V Pengo - Thrombosis Research, 2022 - Elsevier
Background Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by
the presence of antiphospholipid antibodies (aPLs) and thrombotic events. The association …

Thrombocytopenia in pregnancy: Diagnosis and approach to management

AM Pishko, LD Levine, DB Cines - Blood reviews, 2020 - Elsevier
Thrombocytopenia during pregnancy presents unique challenges for the hematologist.
Obstetricians generally manage many of the pregnancy-specific etiologies, ranging from the …

An update on the biologics for the treatment of antiphospholipid syndrome

Z Yun, L Duan, X Liu, Q Cai, C Li - Frontiers in Immunology, 2023 - frontiersin.org
Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
thrombosis and pregnancy morbidity with the persistent presence of antiphospholipid …

Hyperthrombotic milieu in COVID-19 patients

MH Kamel, W Yin, C Zavaro, JM Francis, VC Chitalia - Cells, 2020 - mdpi.com
COVID-19 infection has protean systemic manifestations. Experience from previous
coronavirus outbreaks, including the current SARS-CoV-2, has shown an augmented risk of …